Dow Up 0.11% Nasdaq Up 0.50%

Theravance Inc. (THRX)

-NasdaqGS
23.56 0.60(2.61%) Aug 29, 4:00PM EDT
Prev Close:22.96
Open:22.99
Bid:22.40 x 500
Ask:29.93 x 100
1y Target Est:29.86
Beta:0.72
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:22.94 - 23.75
52wk Range:20.23 - 34.53
Volume:495,536
Avg Vol (3m):1,132,400
Market Cap:2.71B
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXUp 2.61%2.71B
AZN96.00B
CBST5.23B
PFE186.36B

Key Statistics

Forward P/E (1 yr):294.50
P/S (ttm):1,164.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.21
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback